Because the dose of PAF-R antagonists which inhibit endotoxin-induced sepsis are typically more than 10-fold higher than those for PAF released during sepsis, it is suggests that protective effect of PAF antagonist may be related in non-specific inhibition [19]. The gene discussed is PCLAF; the disease is Sepsis.